Glaukos PE Ratio 2014-2023 | GKOS
Current and historical p/e ratio for Glaukos (GKOS) from 2014 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Glaukos PE ratio as of December 08, 2023 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Glaukos PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2023-12-08 | 63.63 | 0.00 | |
| 2023-09-30 | 75.25 | $-2.69 | 0.00 |
| 2023-06-30 | 71.21 | $-2.64 | 0.00 |
| 2023-03-31 | 50.10 | $-2.92 | 0.00 |
| 2022-12-31 | 43.68 | $-2.09 | 0.00 |
| 2022-09-30 | 53.24 | $-1.90 | 0.00 |
| 2022-06-30 | 45.42 | $-1.19 | 0.00 |
| 2022-03-31 | 57.82 | $-0.61 | 0.00 |
| 2021-12-31 | 44.44 | $-1.08 | 0.00 |
| 2021-09-30 | 48.17 | $-0.85 | 0.00 |
| 2021-06-30 | 84.83 | $-1.33 | 0.00 |
| 2021-03-31 | 83.93 | $-1.85 | 0.00 |
| 2020-12-31 | 75.26 | $-2.73 | 0.00 |
| 2020-09-30 | 49.52 | $-1.65 | 0.00 |
| 2020-06-30 | 38.42 | $-1.67 | 0.00 |
| 2020-03-31 | 30.86 | $-0.94 | 0.00 |
| 2019-12-31 | 54.47 | $0.26 | 209.50 |
| 2019-09-30 | 62.51 | $-0.54 | 0.00 |
| 2019-06-30 | 75.40 | $-0.36 | 0.00 |
| 2019-03-31 | 78.37 | $-0.34 | 0.00 |
| 2018-12-31 | 56.17 | $-0.38 | 0.00 |
| 2018-09-30 | 64.90 | $-0.39 | 0.00 |
| 2018-06-30 | 40.64 | $-0.16 | 0.00 |
| 2018-03-31 | 30.83 | $-0.11 | 0.00 |
| 2017-12-31 | 25.65 | $-0.01 | 0.00 |
| 2017-09-30 | 33.00 | $-0.04 | 0.00 |
| 2017-06-30 | 41.47 | $-0.05 | 0.00 |
| 2017-03-31 | 51.30 | $0.11 | 466.36 |
| 2016-12-31 | 34.30 | $0.12 | 285.83 |
| 2016-09-30 | 37.74 | $0.05 | 754.80 |
| 2016-06-30 | 29.16 | $-0.05 | 0.00 |
| 2016-03-31 | 16.86 | $-1.41 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $3.105B | $0.283B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $189.233B | 23.03 |
| Intuitive Surgical (ISRG) | United States | $109.290B | 73.04 |
| DexCom (DXCM) | United States | $45.194B | 86.64 |
| IDEXX Laboratories (IDXX) | United States | $44.130B | 54.22 |
| Edwards Lifesciences (EW) | United States | $41.958B | 27.56 |
| IQVIA Holdings (IQV) | United States | $39.289B | 23.45 |
| Alcon (ALC) | Switzerland | $35.498B | 29.15 |
| STERIS (STE) | Ireland | $19.809B | 24.01 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.886B | 0.00 |
| Waters (WAT) | United States | $17.273B | 24.41 |
| Hologic (HOLX) | United States | $16.409B | 17.31 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.106B | 15.28 |
| Sysmex ADR (SSMXY) | Japan | $11.574B | 34.06 |
| Teleflex (TFX) | United States | $10.861B | 16.92 |
| Penumbra (PEN) | United States | $8.647B | 150.36 |
| ShockWave Medical (SWAV) | United States | $6.427B | 27.13 |
| Globus Medical (GMED) | United States | $6.409B | 20.05 |
| Masimo (MASI) | United States | $5.514B | 30.34 |
| Inari Medical (NARI) | United States | $3.631B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $3.226B | 13.10 |
| Elekta AB (EKTAY) | Sweden | $3.049B | 23.38 |
| Integer Holdings (ITGR) | United States | $2.984B | 20.40 |
| LivaNova (LIVN) | United Kingdom | $2.501B | 16.88 |
| TransMedics (TMDX) | United States | $2.380B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $2.297B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.259B | 18.82 |
| PROCEPT BioRobotics (PRCT) | United States | $1.986B | 0.00 |
| Veracyte (VCYT) | United States | $1.871B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.732B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.566B | 0.00 |
| OPKO Health (OPK) | United States | $1.260B | 0.00 |
| RxSight (RXST) | United States | $1.254B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.982B | 15.00 |
| Paragon 28 (FNA) | United States | $0.950B | 0.00 |
| SiBone (SIBN) | United States | $0.783B | 0.00 |
| Artivion (AORT) | United States | $0.741B | 90.35 |
| Nevro (NVRO) | United States | $0.722B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.713B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.586B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.555B | 17.28 |
| IRadimed (IRMD) | United States | $0.526B | 32.35 |
| Pulse Biosciences (PLSE) | United States | $0.522B | 0.00 |
| CVRx (CVRX) | United States | $0.503B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.432B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.379B | 0.00 |
| AxoGen (AXGN) | United States | $0.323B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.313B | 11.50 |
| Semler Scientific (SMLR) | United States | $0.310B | 18.02 |
| AngioDynamics (ANGO) | United States | $0.277B | 0.00 |
| Accuray (ARAY) | United States | $0.257B | 0.00 |
| 908 Devices (MASS) | United States | $0.226B | 0.00 |
| NeuroPace (NPCE) | United States | $0.221B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.191B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.165B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.140B | 0.00 |
| Inogen (INGN) | United States | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.109B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.108B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.106B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.082B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.071B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.066B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.061B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.061B | 0.00 |
| Vasomedical (VASO) | United States | $0.060B | 4.61 |
| InspireMD (NSPR) | Israel | $0.055B | 0.00 |
| Eargo (EAR) | United States | $0.054B | 0.00 |
| Neuronetics (STIM) | United States | $0.053B | 0.00 |
| DarioHealth (DRIO) | United States | $0.051B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.047B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.040B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.037B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.028B | 0.00 |
| LENSAR (LNSR) | United States | $0.025B | 0.00 |
| PAVmed (PAVM) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| PetVivo Holdings (PETV) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.013B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.012B | 0.00 |
| Sientra (SIEN) | United States | $0.008B | 0.00 |
| Venus Concept (VERO) | Canada | $0.007B | 0.00 |
| Nemaura Medical (NMRD) | United States | $0.006B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Avinger (AVGR) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
